• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高分辨率结构和伴有 DLBCL 形态的淋巴瘤中重排的伙伴基因。

High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology.

机构信息

Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.

Institute of Human Genetics, University of Ulm and Ulm University Medical Center, Ulm, Germany.

出版信息

Blood Adv. 2018 Oct 23;2(20):2755-2765. doi: 10.1182/bloodadvances.2018023572.

DOI:10.1182/bloodadvances.2018023572
PMID:30348671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6199666/
Abstract

Genomic rearrangements in the locus occur in ∼12% of lymphomas with diffuse large B-cell lymphoma (DLBCL) morphology and are associated with inferior outcome. Previous studies exploring rearrangements have primarily used fluorescence in situ hybridization (FISH) assays to characterize break-apart status but have rarely examined breakpoint location, and in some cases have not examined partner identity. We performed targeted sequencing of , , , and the immunoglobulin () loci in 112 tumors with DLBCL morphology harboring rearrangement. We characterized the location of the rearrangement at base pair resolution and identified the partner in 88 cases. We observed a cluster of breakpoints upstream of the coding region and in intron 1 (the "genic cluster"). Genic cluster rearrangements were enriched for translocations involving (80%), whereas nongenic rearrangements occurred mostly downstream of the gene with a variety of partners, including and Other recurrent partners included , , and , which has not previously been described as a partner. We compared 2 commercially available FISH break-apart assays for the locus and observed discordant results in 32% of cases examined, including some with - and - rearrangements. In cases of high-grade B-cell lymphoma with and and/or rearrangement (HGBL-DH), so-called "double-hit" lymphomas, the majority of rearrangements had non- partners (65%), with breakpoints outside the genic cluster (72%). In patients with de novo HGBL-DH of DLBCL morphology, - rearrangements showed a trend toward inferior time to progression and overall survival compared with -non- rearrangements. Our data reveal clinically relevant architecture of rearrangements in lymphomas with DLBCL morphology.

摘要

基因在 12%的具有弥漫性大 B 细胞淋巴瘤 (DLBCL) 形态的淋巴瘤中发生重排,与预后不良相关。以前的研究主要使用荧光原位杂交 (FISH) 检测来探索 重排,以确定断裂分离状态,但很少检查断点位置,在某些情况下也没有检查伙伴身份。我们对 112 例具有 DLBCL 形态且存在 重排的肿瘤进行了靶向测序,这些肿瘤包括 、 、 和免疫球蛋白 ( ) 基因座。我们以碱基分辨率对 重排的位置进行了特征描述,并在 88 例中确定了伙伴。我们观察到在 编码区上游和内含子 1(“基因簇”)处存在断点簇。基因簇重排主要富集涉及 的易位 (80%),而非基因重排主要发生在 基因下游,涉及多种伙伴,包括 和 。其他常见的伙伴包括 、 和 ,以前尚未描述为 伙伴。我们比较了两种市售的针对 基因座的 FISH 断裂分离检测方法,在检查的 32%的病例中观察到不一致的结果,包括一些具有 和 - 重排的病例。在具有 和 以及/或 重排的高级别 B 细胞淋巴瘤 (HGBL-DH),即所谓的“双打击”淋巴瘤中,大多数 重排具有非伙伴 (65%),且断点位于基因簇外 (72%)。在具有 DLBCL 形态的新发 HGBL-DH 患者中,与 -非- 重排相比,- 重排的疾病进展时间和总生存期有下降趋势。我们的数据揭示了具有 DLBCL 形态的淋巴瘤中 重排的临床相关结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67f/6199666/23cfb455051f/advances023572absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67f/6199666/23cfb455051f/advances023572absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67f/6199666/23cfb455051f/advances023572absf1.jpg

相似文献

1
High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology.高分辨率结构和伴有 DLBCL 形态的淋巴瘤中重排的伙伴基因。
Blood Adv. 2018 Oct 23;2(20):2755-2765. doi: 10.1182/bloodadvances.2018023572.
2
Inferior survival in high-grade B-cell lymphoma with and and/or rearrangements is not associated with gene rearrangements.伴有 和/或 重排的高级别 B 细胞淋巴瘤患者的生存情况较差,但与 基因重排无关。
Haematologica. 2018 Nov;103(11):1899-1907. doi: 10.3324/haematol.2018.190157. Epub 2018 Jun 14.
3
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).发病机制和影响因素:MYC 和 BCL2 重排的高级别 B 细胞淋巴瘤中的 MYC 重排(一项 LLMPP 研究)。
Blood. 2024 Aug 1;144(5):525-540. doi: 10.1182/blood.2024024251.
4
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry.伴有 MYC 和 BCL2 及/或 BCL6 重排的高级别 B 细胞淋巴瘤:来自斯洛伐克淋巴瘤登记处的 70 例病例的活检分析。
Neoplasma. 2022 Jul;69(4):957-964. doi: 10.4149/neo_2022_220318N300. Epub 2022 Jun 2.
5
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.双打击基因表达特征定义了生发中心 B 细胞样弥漫性大 B 细胞淋巴瘤的一个独特亚群。
J Clin Oncol. 2019 Jan 20;37(3):190-201. doi: 10.1200/JCO.18.01583. Epub 2018 Dec 3.
6
Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.结直肠弥漫性大 B 细胞淋巴瘤:免疫球蛋白基因易位的分子分类和预后意义。
Hum Pathol. 2020 Feb;96:67-78. doi: 10.1016/j.humpath.2019.09.003. Epub 2019 Nov 15.
7
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.MYC-IG 重排是接受免疫化疗治疗的弥漫性大 B 细胞淋巴瘤患者生存的负预测因子:GELA/LYSA 研究。
Blood. 2015 Nov 26;126(22):2466-74. doi: 10.1182/blood-2015-05-647602. Epub 2015 Sep 15.
8
Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.弥漫性大B细胞淋巴瘤中新型IGH和MYC易位伙伴
Genes Chromosomes Cancer. 2016 Dec;55(12):932-943. doi: 10.1002/gcc.22391. Epub 2016 Jul 12.
9
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.弥漫性大 B 细胞淋巴瘤中 MYC、BCL2 和/或 BCL6 额外拷贝的预后影响:与双/三打击淋巴瘤和双表达淋巴瘤的比较。
Diagn Pathol. 2019 Jul 17;14(1):81. doi: 10.1186/s13000-019-0856-7.
10
Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL.二代测序检测弥漫性大B细胞淋巴瘤中MYC、BCL2和BCL6重排的特征及临床价值
Am J Surg Pathol. 2024 Aug 1;48(8):919-929. doi: 10.1097/PAS.0000000000002258. Epub 2024 Jun 28.

引用本文的文献

1
Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma.MYC完整型和MYC重排型生发中心B细胞弥漫性大B细胞淋巴瘤中的选择性增强子依赖性
Blood Cancer Discov. 2025 May 5;6(3):233-253. doi: 10.1158/2643-3230.BCD-24-0126.
2
Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis.识别乳腺癌患者基因组中因爱泼斯坦-巴尔病毒感染而失效的保护机制:染色体生物信息学分析
JMIRx Med. 2025 Jan 29;6:e50712. doi: 10.2196/50712.
3
Audit of B-cell cancer genes.

本文引用的文献

1
High-grade B-cell lymphoma with and and/or rearrangements with diffuse large B-cell lymphoma morphology.伴有 和/或 重排的高级别 B 细胞淋巴瘤,伴弥漫性大 B 细胞淋巴瘤形态学特征。
Blood. 2018 May 3;131(18):2060-2064. doi: 10.1182/blood-2017-12-820605. Epub 2018 Feb 23.
2
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.一个 Myc 增强子簇调节正常和白血病造血干细胞层级。
Nature. 2018 Jan 25;553(7689):515-520. doi: 10.1038/nature25193. Epub 2018 Jan 17.
3
How I treat double-hit lymphoma.我是如何治疗双打击淋巴瘤的。
B细胞癌基因的审计。
Blood Adv. 2025 Apr 22;9(8):2019-2031. doi: 10.1182/bloodadvances.2022009461.
4
A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine Practice.根据世界卫生组织第五版和国际共识分类对大B细胞淋巴瘤的诊断方法及常规实践中的实用算法
Int J Mol Sci. 2024 Dec 9;25(23):13213. doi: 10.3390/ijms252313213.
5
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma.儿童和青年的 MYC 重排成熟 B 细胞淋巴瘤在分子上为伯基特淋巴瘤。
Blood Cancer J. 2024 Oct 7;14(1):171. doi: 10.1038/s41408-024-01153-0.
6
[A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas].[下一代测序与荧光原位杂交法检测B细胞淋巴瘤基因重排的一致性比较]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):561-565. doi: 10.3760/cma.j.cn121090-20231225-00340.
7
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.不平衡的 MYC 断裂分离 FISH 模式表明 HGBCL-DH-BCL2 中存在 MYC 重排。
Blood. 2024 Oct 10;144(15):1611-1616. doi: 10.1182/blood.2024025603.
8
Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL.二代测序检测弥漫性大B细胞淋巴瘤中MYC、BCL2和BCL6重排的特征及临床价值
Am J Surg Pathol. 2024 Aug 1;48(8):919-929. doi: 10.1097/PAS.0000000000002258. Epub 2024 Jun 28.
9
Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen.通过CRISPR干扰筛选鉴定出非霍奇金淋巴瘤细胞存活所必需的免疫球蛋白重链增强子中的核心区域。
Haematologica. 2024 Dec 1;109(12):4007-4020. doi: 10.3324/haematol.2023.284672.
10
Performance of , , and break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.在小活检标本中应用 、 及 分裂型荧光原位杂交技术检测大B细胞淋巴瘤:一项回顾性细胞病理学与血液病理学机构间联合研究
Front Oncol. 2024 Jun 6;14:1408238. doi: 10.3389/fonc.2024.1408238. eCollection 2024.
Blood. 2017 Aug 3;130(5):590-596. doi: 10.1182/blood-2017-04-737320. Epub 2017 Jun 9.
4
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region.生发中心特异性基因座控制区锚定的B细胞亲和力成熟过程中基因组的多层次重组
Immunity. 2016 Sep 20;45(3):497-512. doi: 10.1016/j.immuni.2016.08.012. Epub 2016 Sep 13.
5
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.B 细胞非霍奇金淋巴瘤中程序性死亡配体结构重排的全面特征描述。
Blood. 2016 Sep 1;128(9):1206-13. doi: 10.1182/blood-2015-11-683003. Epub 2016 Jun 7.
6
Mechanisms of human lymphoid chromosomal translocations.人类淋巴样染色体易位的机制。
Nat Rev Cancer. 2016 May 25;16(6):387-98. doi: 10.1038/nrc.2016.40.
7
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
8
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.MYC和BCL6同时重排及表达对初发弥漫性大B细胞淋巴瘤的预后影响
Oncotarget. 2016 Jan 19;7(3):2401-16. doi: 10.18632/oncotarget.6262.
9
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.MYC-IG 重排是接受免疫化疗治疗的弥漫性大 B 细胞淋巴瘤患者生存的负预测因子:GELA/LYSA 研究。
Blood. 2015 Nov 26;126(22):2466-74. doi: 10.1182/blood-2015-05-647602. Epub 2015 Sep 15.
10
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.增强子相关重排的检测揭示了B细胞淋巴瘤中癌基因失调的机制。
Cancer Discov. 2015 Oct;5(10):1058-71. doi: 10.1158/2159-8290.CD-15-0370. Epub 2015 Jul 30.